SimBioSys, Inc.

TumorSight Viz Validated in Peer-Reviewed Study! We’re thrilled to share that TumorSight Viz, our FDA-cleared AI-powered visualization platform, has been featured in a groundbreaking study published in Nature Breast Cancer! This cutting-edge tool aids in precision breast cancer surgery by providing accurate 3D visualizations and quantitative insights based on routine DCE-MRI. Key Highlights: - 3D Visualization: Detailed mapping of tumors and surrounding tissues for enhanced treatment planning. - Clinical Metrics: Automated measurements of tumor dimensions, tumor-to-landmark distances, and surgical margins, validated to align with expert radiologist annotations. - Accuracy: High overlap and precision in tumor segmentation, with robust performance comparable to radiologist standards. This study underscores our commitment to improving precision surgery and patient outcomes. TumorSight Viz empowers surgeons to make informed decisions and personalize care like never before. Read the full article here: https://lnkd.in/gARVTP-X. #BreastCancerCare #PrecisionOncology #Innovation #TumorSightViz

We’re thrilled to announce that TumorSight? Viz has achieved its second FDA clearance! With this new milestone, our platform is designed to support an unprecedented level of precision in breast cancer surgery. The enhanced TumorSight Viz processes images with AI in a matter of minutes, integrates cutting-edge AI segmentation, provides seamless PACS connectivity for MRI access, and now features a groundbreaking Clinical Decision Support (CDS) tool. This CDS functionality empowers breast surgeons with data-driven insights and supports their efforts in tailoring surgeries to each patient’s unique tumor profile. As NCCN guidelines shift towards less invasive options, TumorSight Viz is designed to support smarter, more informed surgical decisions for optimal patient outcomes. Together, we’re redefining precision medicine! #TumorSightViz #FDAclearance #BreastCancerCare #PrecisionMedicine #SimBioSys

?? We’re thrilled to be featured in NVIDIA’s latest blog, highlighting our collaboration to redefine precision medicine in breast cancer care! ?? At SimBioSys, our mission is to empower healthcare providers with cutting-edge tools on our digital precision medicine platform, TumorSight, leveraging the power of advanced AI and GPU technology from NVIDIA. Together, we’re working to transform how breast cancer is treated, enabling more precise, individualized care for patients worldwide. A huge thank you to the NVIDIA team for recognizing our work's impact and being such an incredible partner on this journey. ?? ?? https://lnkd.in/gdbD2SwK #SimBioSys #NVIDIA #PrecisionMedicine #BreastCancer #HealthcareInnovation #AIinHealthcare #TumorSight #SimBioSys #NVIDIA #PrecisionMedicine #BreastCancer #HealthcareInnovation #AIinHealthcare #TumorSight

We’re honored to be recognized as a key healthcare AI partner by Kimberly Powell from NVIDIA at the 2024 HLTH Conference in Las Vegas, happening from October 20th to 23rd. If you’re attending the conference, we’d love to connect—just send us a DM! If you’re not attending but still want to chat, feel free to reach out as well! #HLTH2024, #NVIDIA, #AI, #Precisionmedicine, #Breastcancer, #Oncology

Breast Cancer Awareness Month: The Power of Early Detection and Precision Surgery October is a time to raise awareness about the importance of early detection in the fight against breast cancer. Early diagnosis saves lives and opens up more treatment options for patients facing critical treatment decisions. At SimBioSys, we're proud to support surgeons with the insights they need to make informed, personalized decisions that benefit their patients most with tools like TumorSight Viz. TumorSight Viz equips surgeons with the data they need to confidently plan less invasive, breast-conserving procedures. Let’s continue raising awareness and advocating for technologies that enhance early detection and offer precise, life-changing treatments for breast cancer. #BreastCancerAwareness #EarlyDetection #BreastConservation #LessInvasiveSurgery #TumorSight #PrecisionMedicine #WomensHealth #SurgicalInnovation #BreastCancerCare

SimBioSys, Inc. applauds the Senate introduction of the bipartisan Find it Early Act which would require Medicare and private payers to cover supplemental imaging for women with dense breasts. We're deeply committed to the fight to personalize breast cancer care. Our revolutionary TumorSight? technology harnesses AI and spatial biophysics to provide surgeons with enhanced visualization and findings unique to each patient's tumor. We're on a mission to unlock a deeper understanding of cancer, empowering more precise and personalized treatments for every patient. #EarlyDetection #WomensHealth #PrecisionMedicine https://lnkd.in/eeFHbXP2

Mercy Medical Center and The Hall-Perrine Cancer Center Gaining Value from Utilizing TumorSight Viz! We’re thrilled to share that Mercy Medical Center is revolutionizing breast cancer surgeries in Cedar Rapids with TumorSight Viz, providing patients with the most advanced, personalized care available. This partnership represents a major leap in surgical precision for Mercy’s patients, utilizing advanced AI and 3D imaging for enhanced visualization. TumorSight Viz provides detailed 3D visualizations that map the tumor’s exact location, volume, and surrounding anatomy. With these crucial insights, breast surgeons can plan and execute surgeries with greater accuracy, enabling them to explore less invasive approaches. A special thanks to Vincent Reid, MD, FACS and the incredible team at Mercy for their commitment to bringing innovative solutions to patient care. We’re proud to collaborate with such forward-thinking physicians and excited for the positive impact TumorSight Viz will have on breast cancer treatment in Iowa. Check out the full article to learn more: https://lnkd.in/gx3BYdnS #HealthcareInnovation #BreastCancerTreatment #AIinHealthcare #SimBioSys #TumorSight #MercyMedicalCenter #SurgicalExcellence #PatientCare?

We are proud to partner with the innovative Mayo Clinic in Digital Health ?? Thank you for the recognition Galen Growth | Insights You Can Trust ?? #AI #Digitalhealth #Precisionmedicine #Breastcancer #oncology

SimBioSys celebrates a great day for women’s health—a day when information and early detection take center stage in the battle against breast cancer! To learn more about this exciting new legislation, please read further! #WomensHealth #BreastCancerAwareness #EarlyDetection #DenseBreastLaw #BreastHealth #CancerScreening #HealthcareInnovation #BreastCancerPrevention #SimBioSys

? Empowering Patients with Modern Technology ? Dr. Allison DiPasquale at Texas Oncology recently shared invaluable advice for breast cancer patients, highlighting modern technology’s role in de-escalating unnecessary care and empowering patients to make informed treatment decisions with their oncology team. Dr. DiPasquale specifically stresses the importance of discussing these options with your medical team, as modern technology enables personalized treatments that can reduce the need for extensive surgery and chemotherapy. TumorSight Viz is one such technology that is changing the game in the breast cancer surgery space. Our advanced AI-powered technology provides surgeons with unparalleled visualization and insights, allowing for more informed surgical decision-making.? Let's spread the word about the power of technology in transforming breast cancer treatment. Together, we can make a difference. ??? #BreastCancerAwareness #ModernMedicine #TumorSightViz #PatientCare #DeescalateTreatment https://lnkd.in/gSU4Gw4Q